![Vasobral [Dihydroergocryptine+Caffeine]](http://amphx.myshopify.com/cdn/shop/products/vasobral__67660.1507157328.1280.1280_{width}x.jpg?v=1566548277)
![Vasobral [Dihydroergocryptine+Caffeine]](http://amphx.myshopify.com/cdn/shop/products/vasobral__67660.1507157328.1280.1280_530x@2x.jpg?v=1566548277)
Vasobral is a combined medication that consists of Dihydroergocryptine and caffeine.
Dihydroergocryptine works by activating dopamine d1/d2 receptors and inhibiting alpha-adrenergic receptors. It is used in Europe in the combination with caffeine since 1979.
Caffeine is the most widely used central nervous system stimulant. It also does improve digestive absorption of Dihydroergocryptine.
Vasobral does improve cerebral metabolism and blood flow and increase mental and physical performance.
Indications for use are:
- Decreased mental capacity, memory and attention impairments caused by aging
- Cerebrovascular insufficiency
- Cerebrovascular disorders
- Migraine prophylaxis
- Vertigo, tinnitus, and hypoacusis of ischemic origin
- Meniere disease
- Diabetic and hypertensive retinopathy
- Raynaud syndrome
- Venous insufficiency